Evaluation of a GSH-targeting prodrug via a sulfonamide-induced “integrative” platform for selective cancer therapy

Analyst, 2020, Advance Article DOI: 10.1039/D0AN00627K, PaperJun Liu, Cheng Cao We propose a novel GSH-generating prodrug to be used with a sulfonamide-induced “integrative” platform for selective cancer therapy. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry

Source: RSC - Analyst latest articles - June 2, 2020 Category: Chemistry Authors: Jun Liu Source Type: research